NDANASALSPRAY, METERED
Approved
Jan 2022
Lifecycle
Peak
Competitive Pressure
0/100
Data completeness
3/8 — Basic
Drug data last refreshed 44m ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
RYALTRIS is a fixed-dose nasal spray combining olopatadine hydrochloride (a selective H1-receptor antagonist) and mometasone furoate (a corticosteroid) for the treatment of allergic rhinitis. The dual mechanism addresses both the allergic cascade and inflammatory response, providing symptom relief through complementary pathways. This is a small-molecule combination therapy administered intranasally.
$0.001BPart D
Peak18.1 years to LOEEarly-stage peak lifecycle positioning with modest Part D penetration suggests ongoing market development and potential for commercial team expansion in sales and market access roles.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
RYALTRIS positions you in a mature peak-lifecycle franchise with long patent exclusivity and modest current market penetration, offering opportunities to build market share and establish brand leadership in allergic rhinitis. Career growth aligns with commercial execution, medical education, and market development rather than clinical innovation.
Brand ManagerProduct Manager
Worked on RYALTRIS at Glenmark Pharms Ltd? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.